AstraZeneca PLC Wins UK Cost Approval for Longer Use of Clot Buster Brilique
Long term use of AstraZeneca's blood thinner Brilinta has been recommended as a cost-effective option for treating patients after a heart attack, Britain's healthcare cost watchdog NICE said on Friday.
Ticagrelor 60 mg -- sold in Britain as Brilique for just under 1 pound ($1.30) a pill -- could help "many thousands of people" when given twice a day alongside aspirin, the National Institute for Health and Care Excellence (NICE) said.
Ticagrelor 60 mg -- sold in Britain as Brilique for just under 1 pound ($1.30) a pill -- could help "many thousands of people" when given twice a day alongside aspirin, the National Institute for Health and Care Excellence (NICE) said.